MK0686
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK0686, covering 2015-06-26 to 2015-11-23. Get the full timeline:
Most recent: Clinical Trial Update: A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005) [Phase 2]